Biblio Discovery — Demo Discovery Service

19 results for "Yohei Funakoshi"

Showing 1–19 · 0.80 seconds · RSS

  1. Journal Article Full text

    Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype

    Yohei Funakoshi; Ying Wang; Takashi Semba et al.

    PLOS ONE, Vol. 14 No. 9 · 2019 · English · PLOS Scopus

    Background: Inflammatory breast cancer (IBC) is an aggressive form of breast cancer. The triple-negative subtype of IBC (TN-IBC) is particularly aggressive. Identification of molecular differences between TN-IBC and TN-non-IBC may help clarify the unique clinical behaviors of TN-IBC. However, our…

    Also available at: DOAJ

  2. Journal Article

    Cytomegalovirus reactivation in esophageal cancer patients receiving chemoradiotherapy: A retrospective analysis

    Koichi Kitagawa; Hideaki Okada; Shuichiro Miyazaki et al.

    Cancer Medicine, Vol. 10 No. 21 · 2021 · English · DOAJ Scopus

    Abstract Background Although rare, cytomegalovirus (CMV) reactivation can be lethal in patients with cancer. However, the criteria for the prevention of cytomegalovirus reactivation during cancer treatment are unclear. This study aimed to identify factors associated with CMV reactivation in…

  3. Journal Article

    LM-QASAS: reference-free identification of antigen-specific sequences from the BCR repertoire using antibody language models

    Genki Masuda; Yohei Funakoshi; Shunsuke Iizumi et al.

    Frontiers in Immunology, Vol. 17 · 2026 · English · DOAJ Scopus

    The B-cell receptor (BCR) repertoire serves as a historical record of immunological events. However, deciphering antigen-specific sequences from this vast dataset remains a challenge, particularly for novel pathogens where prior knowledge is absent. While time-course analysis methods such as QASAS…

  4. Journal Article

    Inhaled corticosteroids do not affect the antibody titer against the SARS-CoV-2 spike protein in BNT162b2 mRNA vaccinated patients

    Takeo Nakajima; Tatsuya Nagano; Yoshiharu Miyata et al.

    Allergy, Asthma & Clinical Immunology, Vol. 18 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Objectives Oral corticosteroids reduce the antibody titer of the BNT162b2 mRNA vaccine against SARS-CoV-2. To date, the effect of inhaled corticosteroids on antibody titers is unknown. Study design The design of this study is retrospective study. Methods We analyzed the relationship…

  5. Journal Article

    Mediastinal Germ Cell Tumor Exhibiting a Discrepancy between Tumor Markers and Imaging: A Case Study

    Kei Takenaka; Toru Mukohara; Chihoko Hirai et al.

    Case Reports in Oncology, Vol. 8 No. 2 · 2015 · English · DOAJ Scopus

    We report a mediastinal germ cell tumor (GCT) that exhibited a discrepancy between the time course of serum human chorionic gonadotropin (hCG) levels and clinical consequences. An otherwise healthy man, aged 34 years, was diagnosed with a nonseminomatous GCT, most likely embryonal carcinoma (EC)…

  6. Journal Article Full text

    Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial)

    Hironobu Goto; Taro Oshikiri; Takashi Kato et al.

    PLOS ONE, Vol. 19 No. 4 · 2024 · English · PLOS Scopus

    Background: In Japan, preoperative adjuvant chemotherapy followed by surgical resection is the standard treatment for patients with locally advanced esophageal squamous cell carcinoma. However, the risk of recurrence after surgical resection remains high. Although a randomized controlled trial…

    Also available at: DOAJ

  7. Journal Article

    Massive surge of mRNA expression of clonal B-cell receptor in patients with COVID-19

    Yohei Funakoshi; Goh Ohji; Kimikazu Yakushijin et al.

    Heliyon, Vol. 7 No. 8 · 2021 · English · DOAJ Scopus

    Background: Antibody production is one of the primary mechanisms for recovery from coronavirus disease 2019 (COVID-19). It is speculated that massive clonal expansion of B cells, which can produce clinically meaningful neutralizing antibodies, occurs in patients who recover on the timing of…

  8. Journal Article

    Analysis of B-cell receptor repertoire to evaluate the immunogenicity of SARS-CoV-2 RBD mRNA vaccine: MAFB-7256a (DS-5670d)

    Goh Ohji; Yohei Funakoshi; Kimikazu Yakushijin et al.

    Frontiers in Immunology, Vol. 15 · 2024 · English · DOAJ Scopus

    A monovalent Omicron XBB.1.5 mRNA RBD analogue vaccine, MAFB-7256a (DS-5670d), was newly developed and approved in Japan in the Spring of 2024 for the prevention of COVID-19. However, clinical efficacy data for this vaccine are currently lacking. We previously established the Quantification of…

  9. Journal Article

    Left atrial extension of metastatic lung tumor via pulmonary vein: report on the first case of Ewing sarcoma

    Hironobu Minami; Kazuhiko Nakagawa; Soichi Fumita et al.

    Rare Tumors, Vol. 2 No. 3 · 2010 · English · DOAJ Scopus

    Extension of metastatic lung tumors into the left atrium via pulmonary veins is rare. Here, we report the first case of Ewing sarcoma exhibiting such extension. A 31-year-old man with pulmonary metastasis from Ewing sarcoma presented with a mass in the left lung, extending to the left atrium…

  10. Journal Article

    B-cell repertoire maturation as a biomarker for immune reconstitution after hematopoietic stem cell transplantation

    Yohei Funakoshi; Kimikazu Yakushijin; Sakuya Matsumoto et al.

    Blood Immunology & Cellular Therapy, Vol. 2 No. 4 · 2026 · English · DOAJ

    Abstract: A method for monitoring adaptive immune reconstitution after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is not available. We developed the probability of generation (pGen)-somatic hypermutation (SHM) plot (pGen-SHM plot) to objectively monitor the long-term…

  11. Journal Article Full text

    Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination

    Yohei Funakoshi; Kimikazu Yakushijin; Goh Ohji et al.

    Vaccines, Vol. 10 No. 6 · 2022 · English · DOAJ Scopus

    Anti-CD20 antibodies react with CD20 expressed not only on malignant B cells, but also on normal B cells. It has been reported that patients treated with anti-CD20 antibodies had an insufficient response to two-dose mRNA SARS-CoV-2 vaccination. To investigate the efficacy of a third dose in these…

  12. Journal Article

    Importance of E/e’ and BNP for early detection of late cardiotoxicity in long-term follow-up of childhood hematologic cancer survivors: a retrospective cross-sectional study

    Yuri Okazoe-Hirakawa; Kimikazu Yakushijin; Keiji Kurata et al.

    Cardio-Oncology, Vol. 11 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Childhood cancer survivors (CCS) often develop late complications after their primary disease is cured. Cardiovascular disease is one of the most frequent and serious complications that significantly affects prognosis and quality of life. Early detection and appropriate…

  13. Journal Article

    Analysis of B‐cell receptor repertoire to evaluate immunogenicity of monovalent Omicron XBB.1.5 mRNA vaccines

    Yohei Funakoshi; Kimikazu Yakushijin; Goh Ohji et al.

    eJHaem, Vol. 5 No. 4 · 2024 · English · DOAJ

    Abstract Monovalent Omicron XBB.1.5 mRNA vaccines were newly developed and approved by the FDA in Autumn 2023 for preventing COVID‐19. However, clinical efficacy for these vaccines is currently lacking. We previously established the quantification of antigen‐specific antibody sequence (QASAS)…

  14. Journal Article Full text

    The Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Japanese Patients after Allogeneic Stem Cell Transplantation

    Marika Watanabe; Kimikazu Yakushijin; Yohei Funakoshi et al.

    Vaccines, Vol. 10 No. 2 · 2022 · English · DOAJ Scopus

    Patients who have undergone hematopoietic stem cell transplantation (HSCT) for hematological disease experience high mortality when infected by coronavirus disease 2019 (COVID-19). However, the safety and efficacy of the COVID-19 vaccine in HSCT patients remain to be investigated. We prospectively…

  15. Journal Article Full text

    A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

    Marika Watanabe; Kimikazu Yakushijin; Yohei Funakoshi et al.

    Vaccines, Vol. 10 No. 11 · 2022 · English · DOAJ Scopus

    We previously reported that a second dose of BNT162b2 was safe and effective for allogeneic hematopoietic stem cell transplantation (HSCT) patients. Here, we investigated the safety and efficacy of a third dose of COVID-19 mRNA vaccine in allogeneic HSCT patients. Antibody titers against the S1…

  16. Journal Article

    AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization

    Lan T. H. Phi; Yating Cheng; Yohei Funakoshi et al.

    Breast Cancer Research, Vol. 27 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Tumor-associated macrophages (TAMs) are key promoters of inflammatory breast cancer (IBC), the most aggressive form of breast cancer. The receptor tyrosine kinase AXL is highly expressed in various cancer types, including IBC, but its role in TAMs remains unexplored. Methods We…

  17. Journal Article

    Preclinical evaluation of the efficacy of an antibody to human SIRPα for cancer immunotherapy in humanized mouse models

    Yasuyuki Saito; Rie Iida-Norita; Tania Afroj et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    Tumor-associated macrophages (TAMs) are abundant in the tumor microenvironment and are considered potential targets for cancer immunotherapy. To examine the antitumor effects of agents targeting human TAMs in vivo, we here established preclinical tumor xenograft models based on immunodeficient mice…